152 related articles for article (PubMed ID: 15677698)
1. Epidermal growth factor receptor inhibitors in colorectal cancer: it's time to get back on target.
Meropol NJ
J Clin Oncol; 2005 Mar; 23(9):1791-3. PubMed ID: 15677698
[No Abstract] [Full Text] [Related]
2. A case of ecthyma during therapy with an epidermal growth factor receptor inhibitor.
Mizuno T; Tanegashima T; Suzuki A; Kuze S; Koyama T
Eur J Dermatol; 2014; 24(4):511-2. PubMed ID: 25266748
[No Abstract] [Full Text] [Related]
3. Targeting the epidermal growth factor receptor in colorectal carcinoma.
Kurtin SE
Cancer Nurs; 2007; 30(4 Suppl 1):S1-9. PubMed ID: 17666985
[TBL] [Abstract][Full Text] [Related]
4. Papulo-pustular eruption during cetuximab treatment.
Satta R; Cuccuru MA; Pirodda C; Cottoni F
G Ital Dermatol Venereol; 2008 Feb; 143(1):87-8. PubMed ID: 18833056
[No Abstract] [Full Text] [Related]
5. Anti-EGFR monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab.
You B; Chen EX
J Clin Pharmacol; 2012 Feb; 52(2):128-55. PubMed ID: 21427284
[TBL] [Abstract][Full Text] [Related]
6. [Molecular targets in colon cancer].
Borner MM
Ther Umsch; 2006 Apr; 63(4):243-8. PubMed ID: 16689454
[TBL] [Abstract][Full Text] [Related]
7. [Adverse effects of new oncologic therapies].
Weisshaupt Ch; Budak K; Pestalozzi B
Praxis (Bern 1994); 2011 Jul; 100(15):885-91; quiz 890. PubMed ID: 21792802
[No Abstract] [Full Text] [Related]
8. Cicatricial ectropion associated with treatment of metastatic colorectal cancer with cetuximab.
Garibaldi DC; Adler RA
Ophthalmic Plast Reconstr Surg; 2007; 23(1):62-3. PubMed ID: 17237696
[TBL] [Abstract][Full Text] [Related]
9. Panitumumab (Vectibix) for metastatic colorectal cancer.
Med Lett Drugs Ther; 2007 Apr; 49(1259):35-6. PubMed ID: 17450113
[No Abstract] [Full Text] [Related]
10. Clinical use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer.
Patel DK
Pharmacotherapy; 2008 Nov; 28(11 Pt 2):31S-41S. PubMed ID: 18980550
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of monoclonal antibodies to the epidermal growth factor receptor in colorectal cancer.
Burtness B
Oncology (Williston Park); 2007 Jul; 21(8):964-70; discussion 970, 974, 976-7. PubMed ID: 17715697
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab in metastatic colorectal cancer.
Broadbridge VT; Karapetis CS; Price TJ
Expert Rev Anticancer Ther; 2012 May; 12(5):555-65. PubMed ID: 22594891
[TBL] [Abstract][Full Text] [Related]
13. New treatment options for colorectal cancer.
Erlichman C; Sargent DJ
N Engl J Med; 2004 Jul; 351(4):391-2. PubMed ID: 15269321
[No Abstract] [Full Text] [Related]
14. Expanding the arsenal for metastatic colorectal cancer: a discussion of current clinical trials.
Bekaii-Saab T
Clin Adv Hematol Oncol; 2009 Jul; 7(7):430-2. PubMed ID: 19701148
[No Abstract] [Full Text] [Related]
15. Promising drug is victim of bad business.
Dove A
Nat Med; 2002 Mar; 8(3):199. PubMed ID: 11875472
[No Abstract] [Full Text] [Related]
16. Re: Cetuximab therapy and symptomatic hypomagnesemia.
Altundag K; Altundag O; Baptista MZ; Turen S; Atik MA
J Natl Cancer Inst; 2005 Dec; 97(23):1791-2. PubMed ID: 16333039
[No Abstract] [Full Text] [Related]
17. [Molecular target therapy for colonic neoplasms].
Oki E; Ota M; Honbo T; Egashira A; Tokunaga E; Sadanaga N; Morita M; Kakeji Y; Maehara Y
Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):289-94. PubMed ID: 17370595
[No Abstract] [Full Text] [Related]
18. Introduction: Emerging therapies with epidermal growth factor receptor-targeted agents in colorectal cancer.
Chu E
Clin Colorectal Cancer; 2005 Nov; 5 Suppl 2():S60-1. PubMed ID: 16336750
[No Abstract] [Full Text] [Related]
19. Does cetuximab cause small bowel perforation?
Ozturk MA; Eren OO; Oyan B
J BUON; 2014; 19(3):865. PubMed ID: 25261682
[No Abstract] [Full Text] [Related]
20. [Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab].
Coquart N; Karam A; Metges JP; Misery L
Ann Dermatol Venereol; 2010 Apr; 137(4):306-7. PubMed ID: 20417368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
